Clay Siegall: Dreaming of Corporate Expansion

Clay Siegall is the founder and the current chief executive officer of Seattle Genetics, one of the largest healthcare, pharmaceutical and tech companies in the state of Washington. The company is known for manufacturing Adcertis, a drug that is used for the treatment of Hodgkin lymphoma, a kind of lymph system cancer that can be fatal if not treated. Clay Siegall stated that he is now planning to expand outside Washington, and it is his ultimate dream for Seattle Genetics to be known all throughout the country, and for the company to be able to manufacture pharmaceutical drugs for international use.

Seattle Genetics was founded in the year 1988, and the reason why Clay Siegall established the company is that he wanted to develop a medical treatment for fatal diseases like cancer. At first, there is only a handful of employees who decided to work with him. Through the years, the number of employees rose, and today, more than a thousand people work for the pharmaceutical firm. Clay Siegall stated that the company’s success could be attributed to the hard-working employees who are contributing a lot for the sake of the business. He stated that with the expansion of Seattle Genetics, more people would be given jobs, and the chances of the medicine that they manufacture to reach more people go up.

The noble cause of Clay Siegall to treat fatal diseases transformed the company from a small startup to one of the most profitable businesses in the state of Washington. The creation of Adcertis is also purely accidental, as Clay Siegall and his team of scientists are working for another cure until they mixed up all of the materials and ended up treating Hodgkin lymphoma. The FDA has approved Adcertis, and it is now being sold in the market. The value of the company at the stock market is also continuing to rise, as more investors are pouring in their money because of the enormous potential of Seattle Genetics to make it big. Aside from Adcertis, Seattle Genetics also have some medicines that are now under tests to see if they can treat different kinds of cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *